Tags
Swedish News Blog Blog

'cancer' Swedish News Blog posts

Guest Column: Select the Right Cancer Treatment

In the second of his three-part Seattle Times guest column series, Swedish Cancer Institute Medical Director for Naturopathic Services Dan Labriola, N. D., guides readers through their options when selecting a cancer treatment approach. In the column, Dr. Labriola examines how patients can weigh the benefits and risks of multiple treatment options, approved therapies vs. clinical trials, how to seek a second opinion and what to do if it is different from your initial evaluation. In his final installment set for next Sunday, Dr. Labriola will discuss survivorship, including complementary and alternative medicine strategies.

The Race Continues…19th Annual SummeRun & Walk Raises $558,000 for Ovarian Cancer Research

SEATTLE — August 12, 2013 — More than 3,500 enthusiastic patients, survivors and supporters gathered in Seattle last month to participate in the 19th annual Swedish presents SummeRun & Walk for ovarian cancer. Thanks to energized and proactive participants, this year’s event raised more than $558,000 in support of ovarian cancer research.


The SummeRun & Walk celebrates and remembers the lives of those who have been impacted by ovarian cancer. It is the Northwest’s largest community event to raise awareness and vital funds for ovarian cancer. Since its inception, the SummeRun has raised more than $6 million for medical research into the treatment, early detection, and prevention of this disease.

Greg Foltz, M.D. – A legacy to remember

SEATTLE, July 3, 2013 – Greg Foltz, M.D., director of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (Ivy Center), passed away from Stage IV pancreatic cancer on Thursday, June 27. Dr. Foltz, who was 50 years old, spent the last 20 years as a pioneer and champion for advancing brain cancer research in the hope of one day finding a cure.

Swedish Celebrates Dr. Saul Rivkin’s Long, Impressive Career as a Devoted, Accomplished Medical Oncologist and Researcher in Fight Against Ovarian Cancer



SEATTLE, June 6, 2013 – Swedish Cancer Institute (SCI) announced today that Saul Rivkin, M.D., medical oncologist, as well as founder and board chair of the Marsha Rivkin Center for Ovarian Cancer Research, will retire from his clinical practice at SCI on July 1, 2013. The highly respected and revered physician, who is 77 years old and has five daughters and seven grandchildren, Dr. Rivkin is best known for his committed, tenacious approach to fighting cancer and the personal connection he has established with the thousands of patients he has cared for over the years.

New Cancer Center to Open April 1 at Swedish/Edmonds; Outpatient Facility to Provide Medical Oncology, Infusion Services Close to Home


 
 


  
Cancer-Center-Opening-2.jpg

Swedish Cancer Institute at Edmonds opens to the public at an April 17 ribbon-cutting ceremony on the Swedish/Edmonds campus. (Left to right) David Loud, aide from Congressman Jim McDermott, M.D.; Swedish Cancer Institute Medical Oncologist Richard McGee, M.D.; Swedish/Edmonds Chief Executive Dave Jaffe; and Swedish Cancer Institute Executive Director Thomas D. Brown, M.D., MBA, cut the ribbon during the event that attracted 250 visitors. The two-story facility, located at 21632 Highway 99 in Edmonds, provides high-quality and comprehensive medical oncology to patients through an infusion unit, laboratory, pharmacy, and access to Swedish’s electronic medical record system.
 
EDMONDS, WASH.
, March 21, 2013 – Swedish Health Services will open a new outpatient cancer center at the Edmonds campus on Monday, April 1, 2013 in response to the growing need for medical oncology and infusion (chemotherapy) services in the south Snohomish and north King County area. The new two-story, 17,102-square-foot facility is anticipated to handle as many as 175 patient visits each day and provide increased access to cancer-care services for people living north of Seattle.

Swedish Offers New Treatment for Glioblastoma Brain Tumors

SEATTLE, Feb. 6, 2013 – Swedish Neuroscience Institute has added a new and innovative therapy to its treatment arsenal for glioblastoma multiforme (GBM) – a very aggressive and difficult to control brain tumor.

Swedish Cancer Institute Names New Executive Director after National Search

SEATTLE, Jan. 31, 2013 – Swedish Cancer Institute (SCI) recently announced the appointment of Thomas D. Brown, M.D., MBA, as its new executive director. Dr. Brown will join SCI March 16.

Results 1-7 of 11